Viewing Study NCT03382795


Ignite Creation Date: 2025-12-24 @ 1:27 PM
Ignite Modification Date: 2026-01-04 @ 9:17 AM
Study NCT ID: NCT03382795
Status: UNKNOWN
Last Update Posted: 2021-07-15
First Post: 2017-12-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients
Sponsor: Korea University Guro Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None EGFR Positive Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epidermal growth factor receptor tyrosine kinase inhibitor View
None Cytotoxic chemotherapy View
None Epidermal growth factor receptor mutation View